CharlesStephenHolladayMDFACP
Oncology • Charleston, SCHematologic Oncology, Thoracic Cancer
Charleston Oncology
Dr. Holladay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2910 Tricom St
Charleston Cancer Center
Charleston, SC 29406Phone+1 843-572-9211Fax+1 843-572-0457
Summary
- Dr. Charles Holladay is an oncologist in Charleston, SC and is affiliated with multiple hospitals in the area, including Bon Secours St. Francis Hospital, HCA South Atlantic - Colleton Medical Center, Roper Hospital, HCA South Atlantic - Summerville Medical Center, HCA South Atlantic - Trident Medical Center, and Roper St. Francis Mount Pleasant Hospital. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 22 years. He specializes in hematologic oncology and thoracic cancer and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.
Education & Training
Medical University of South CarolinaFellowship, Hematology and Medical Oncology, 2001
Medical University of SC1998- Medical University of South CarolinaInternship, Internal Medicine, 1995 - 1996
- Medical University of South CarolinaClass of 1995
Certifications & Licensure
SC State Medical License 1996 - 2025- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting Start of enrollment: 2010 Dec 02
- PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score Start of enrollment: 2012 May 01
Publications & Presentations
PubMed
- 77 citationsMulticenter Randomized Phase II Study of Weekly or Twice-Weekly Bortezomib Plus Rituximab in Patients With Relapsed or Refractory Follicular or Marginal-Zone B-Cell Ly...Sven de Vos, Andre Goy, Shaker R. Dakhil, Mansoor N. Saleh, Peter McLaughlin
Journal of Clinical Oncology. 2009-10-20 - 12 citationsDeoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ...Kapil N. Bhalla, Charles Holladay, Jose Lutzky, Ana Maria Ibrado, Gloria Bullock
Gynecologic Oncology. 1992-04-01 - 5 citationsEffect of combined treatment with interleukin-3 and interleukin-6 on 4-hydroperoxycyclophosphamide-mediated reduction of glutathione levels and cytotoxicity in normal ...Kapil N. Bhalla, Gloria Bullock, Jose Lutzky, Charles Holladay, Ana Maria Ibrado
Leukemia. 1992-01-01
Professional Memberships
- Member
- Fellow
- Member
External Links
- Websitehttp://www.charlestoncancer.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
